Explicit measurement of multi-tracer arterial input function for PET imaging using blood sampling spectroscopy by Velasco, Carlos et al.
ORIGINAL RESEARCH Open Access
Explicit measurement of multi-tracer
arterial input function for PET imaging
using blood sampling spectroscopy
Carlos Velasco1,2, Adriana Mota-Cobián1,2, Jesús Mateo1 and Samuel España1,2*
* Correspondence: sespana@ucm.es
1Centro Nacional de Investigaciones
Cardiovasculares (CNIC), Madrid,
Spain
2Departamento de Estructura de la
Materia, Física Térmica y Electrónica,
Facultad de Ciencias Físicas, Ciudad
Universitaria, Universidad
Complutense de Madrid, IdISSC,
28040 Madrid, Spain
Abstract
Background: Conventional PET imaging has usually been limited to a single tracer
per scan. We propose a new technique for multi-tracer PET imaging that uses
dynamic imaging and multi-tracer compartment modeling including an explicitly
derived arterial input function (AIF) for each tracer using blood sampling
spectroscopy. For that purpose, at least one of the co-injected tracers must be based
on a non-pure positron emitter.
Methods: The proposed technique was validated in vivo by performing cardiac PET/
CT studies on three healthy pigs injected with 18FDG (viability) and 68Ga-DOTA
(myocardial blood flow and extracellular volume fraction) during the same
acquisition. Blood samples were collected during the PET scan, and separated AIF for
each tracer was obtained by spectroscopic analysis. A multi-tracer compartment
model was applied to the myocardium in order to obtain the distribution of each
tracer at the end of the PET scan. Relative activities of both tracers and tracer uptake
were obtained and compared with the values obtained by ex vivo analysis of excised
myocardial tissue segments.
Results: A high correlation was obtained between multi-tracer PET results, and those
obtained from ex vivo analysis (18FDG relative activity: r = 0.95, p < 0.0001; SUV: r =
0.98, p < 0.0001).
Conclusions: The proposed technique allows performing PET scans with two tracers
during the same acquisition obtaining separate information for each tracer.
Keywords: Arterial input function, Positron emission tomography, Multi-tracer PET,
Gamma spectroscopy
Background
Positron emission tomography (PET) is a diagnostic molecular imaging technique that
allows in vivo monitoring of metabolic processes within the body based on the biodis-
tribution of a radiotracer that is administered to the patient. The wide variety of avail-
able radiotracers provides access to different biological aspects such as glucose
metabolism, cell proliferation, hypoxia, or blood flow. Among the different radiotracers
available, each one shows strengths and limitations for a particular clinical application
[1]. Therefore, the nuclear medicine physician selects the tracer that will provide the
most specific and reliable information for the patient under study. However, in many
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clinical cases, diagnostic accuracy can be increased considerably if complementary in-
formation is obtained from different tracers. An example of diagnosis using multiple
tracers is found in ischemic heart disease, which includes evaluation of myocardial
blood flow (MBF) using tracers like 13NH3, H2
15O, or 82Rb and assessment of myocar-
dial metabolism and viability using 18FDG. In this way, a better understanding of the
pathophysiology of ischemic heart disease is obtained [2].
Conventional PET imaging has usually been limited to a single tracer per scan.
Therefore, in order to perform PET examinations with multiple tracers on the same pa-
tient, different scans should be performed sequentially if the half-life of one tracer is
short enough (i.e., tracers based on 13N, 15O, or 82Rb) to allow fast clearance of the
tracer before the next tracer is administered. Otherwise, scans can be performed in dif-
ferent days. These procedures lead to extended scan time and to increased cost and
complexity of patient management. Those limitations can be diminished by performing
PET imaging on patients that have been administered with multiple radiotracers. How-
ever, multi-tracer PET imaging is still a challenging approach as annihilation photon
pairs emitted from either tracer are indistinguishable. Therefore, some extra informa-
tion is needed to disentangle the signal coming from each tracer.
Two main strategies have been proposed so far in order to enable the possibility of
performing PET scans with multiple tracers simultaneously. The first approach uses dy-
namic imaging with staggered injections. In this case, a multi-tracer compartment
model is used to separate the contribution from each tracer. However, different con-
straints must be applied on the kinetic behavior in order to separate each tracer contri-
bution from the multi-tracer PET signal [3–5]. In the second approach, at least one of
the injected tracers must be labeled with a radioisotope that emits a prompt gamma in
addition to the positron, which can be detected in coincidence with the annihilation
photons [6]. With this additional information, the signal coming from both tracers can
be isolated by energy discrimination within the PET scanner. However, a relatively high
(> 10%) branching ratio of the prompt gamma is required in this case, reducing the list
of candidate radioisotopes to 124I or those with similar prompt gamma branching ratio.
In this study, we propose a new technique for multi-tracer PET imaging that uses dy-
namic imaging and multi-tracer compartment modeling including an explicitly derived
arterial input function (AIF) for each tracer. For that purpose, PET studies should be
performed with at least one of the co-injected tracers based on a non-pure positron
emitter [7], i.e., which produces additional gamma emissions. In order to end up with a
separate AIF for each radiotracer, blood samples are collected during the acquisition
and further analyzed by gamma spectroscopy. Once separate AIFs are obtained, multi-
tracer compartment modeling is applied to determine the kinetic parameters associated
with each tracer. Using this methodology, no constraints to the kinetic behavior are re-
quired. In addition, clinically promising isotopes like 68Ga [8], which has a very low
branching ratio for the extra gamma photons, can be combined with other regular iso-
topes like 18F. The proposed methodology was implemented and validated in pigs by a
combination of two tracers for cardiac PET imaging, namely 68Ga-DOTA and 18FDG.
While 18FDG is a very well-known tracer used in myocardial viability studies among
other cardiac applications [9], 68Ga-DOTA has been recently proposed as a new PET
tracer for MBF and extracellular volume fraction (ECV) determination [10–13] as well
as for pulmonary blood flow [14].
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Methods
Study design and experiment overview
In the first place, in vitro studies were performed as a proof of concept of our proposed
methodology. Samples containing unknown mixtures of two isotopes (18F and 68Ga)
were analyzed by means of gamma spectroscopy. Several calibration procedures were
carried out in order to obtain the individual contribution of each tracer. For in vivo
studies, 18FDG and 68Ga-DOTA tracers were administered to healthy pigs, and dy-
namic PET scans were performed. Manual blood samples were collected throughout
the PET scan and analyzed by gamma spectroscopy to obtain a separate AIF for each
tracer. A multi-tracer compartment model was applied to the dynamic PET imaging
using those explicitly separated AIFs. Finally, the model was used to determine the up-
take of each tracer at the end of the PET scan on each segment of the myocardium,
and the results were compared with those obtained ex vivo directly from myocardial
tissue. To do so, animals were sacrificed, and the heart was excised in segments that
were further analyzed to determine the individual uptake of each tracer ex vivo. A sche-
matic drawing of the experimental protocol is shown in Fig. 1.
In vitro tracer separation by gamma spectroscopy
We analyzed different combinations of two tracers, one based on a pure positron emit-
ter (18F) and the other one based on a non-pure positron emitter (68Ga). While 18F only
emits annihilation photons of 511 keV, 68Ga emits additional photons, but only those
emitted at 1.077MeV have a significant contribution (3.22%). Therefore, a sample con-
taining an unknown combination of both isotopes could be analyzed by means of
gamma spectroscopy. To determine the concentration of each tracer in a sample, a
methodology was developed using a well counter (Wallac 1470 Perkin Elmer, Waltham,
MA, USA) configured to record events during 1 min at different energy windows simul-
taneously, one of them covering the entire energy spectrum (200–2000 keV, hereafter
named as W200–2000) and the other one covering only high-energy emissions (900–
2000 keV, hereafter named as W900–2000). Dead time correction and background sub-
traction were implemented but not decay correction due to the unknown isotope com-
bination. The amount of 68Ga and 18F contained in the sample was derived using the
ratio (QS) between events recorded at W200–2000 and W900–2000 energy windows as ex-
plained below.
The relationship between QS and the relative activity of
68Ga (RGa) and
18F (RF) in a
sample (i.e., the individual fractional contribution of 68Ga and 18F to the total activity
of the sample) was calibrated using a set of 68Ga/18F mixtures. Seven 1-ml samples
were prepared containing 68Ga to 18F activity ratios 1:0, 9:1, 4:1, 3:2, 2:3, 1:4, and 0:1.
These samples were analyzed in the well counter, and the QS values were represented
against the known relative activities obtaining a linear relationship (see Fig. 2). Decay
correction was applied to recorded values. Since in the subsequent animal studies,
blood samples may be collected with different sample volumes (VS); a calibration had
to be performed to account for variations in the detection efficiency of gamma photons
with different energy and different geometrical distribution. For that purpose, QS values
were recorded using pure 18F (QF(V)) and
68Ga (QGa(V)) samples (~ 20 kBq each) with
volumes ranging from 50 to 2000 μl (see Fig. 3). For known QF(V) and QGa(V) within a
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sufficiently wide volume range, RGa and RF can be obtained for a sample with known
volume Vs by solving the following equations:
Qs V Sð Þ ¼ RGa  QGa V Sð Þ þ RF  QF V Sð Þ ð1aÞ
RGa þ RF ¼ 1 ð1bÞ
Afterwards, the absolute activity concentrations of each tracer (i.e., AF and AGa) can
be obtained for a sample of known volume VS as follows:
AF kBq ml−1




  ¼ Atot  RGa
V S
ð2bÞ
where Atot is the total activity of the sample and can be derived from the following
equation:
Fig. 1 Schematic drawing of the study design. a Firstly, our proposed tracer separation methodology based on
gamma spectroscopy was evaluated in vitro as a proof of concept. A calibration protocol was established to
obtain the activity concentrations of each radioisotope for samples containing an unknown combination of 18F
and 68Ga. b Afterwards, this methodology was implemented in vivo. To do so, three pigs underwent 45-min
cardiac dynamic PET/CT scans in which 68Ga-DOTA and 18FDG were injected with a 5-min time gap. After PET/
CT examinations, the animals were sacrificed, and their hearts excised, divided into segments, and analyzed to
obtain the activity concentration of 18FDG and 68Ga-DOTA inside each segment. These results were compared
against those obtained in vivo by parallel multi-tracer pharmacokinetic on the same regions of interest (ROIs) of
their hearts. Explicitly separated AIFs needed for the pharmacokinetic analysis were obtained with our proposed
method by gamma spectroscopy of a set of blood samples withdrawn during the scan
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W 200−2000 ¼ W F þWGa ¼ Atot εFRF þ εGaRGað Þ ð3Þ
where WF and WGa are the events recorded for each isotope, and εF and εGa are
volume-dependent calibration factors obtained from pure 18F and 68Ga samples re-
spectively (Fig. 4).
Finally, before the kinetic model can be individually applied for each tracer, AF and
AGa were converted to β
+decays·s−1 ml−1 multiplying by the branching ratio in order to
match the units obtained from the PET images.
Fig. 2 Calibration of QS values of a set of 1 ml samples with mixed
68Ga and 18F in different activity ratios.
The linear fit (dashed line) shows an excellent linear correlation (r2 = 0.9992) between both datasets
Fig. 3 Variation of QS values measured with the well counter for pure
18F (red squares) and 68Ga (blue
circles) with different sample volumes (VS). Results were fitted to a straight line and a sum of two
exponentials respectively in order to obtain the QS values for different volumes
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Following this procedure, explicitly separated AIFs can be obtained from a multi-
tracer PET scan by analyzing a set of blood samples withdrawn from the subject
throughout the study and obtaining AF and AGa for each timepoint. The feasibility of
this methodology was investigated in animal studies as described below.
Animal protocol
The in vivo study was conducted according to the guidelines of the current European Dir-
ective and Spanish legislation and approved by the regional ethical committee for animal
experimentation. Three healthy female white large pigs (mean weight = 45 ± 4 kg) were
anesthetized by intramuscular injection of ketamine (20mg/kg), xylazine (2mg/kg), and
midazolam (0.5mg/kg) and maintained by continuous intravenous infusion of ketamine
(2mg/kg/h), xylazine (0.2mg/kg/h), and midazolam (0.2mg/kg/h). Oxygen saturation
levels via pulse oximetry and electrocardiogram signal were monitored throughout the
study. The coccygeal artery of the animal was cannulated and connected to a peristaltic
pump placed as close as possible to minimize blood dispersion inside the tubing.
PET/CT image acquisition
PET/CT images were acquired using a Gemini TF-64 scanner (Philips Healthcare, Best,
The Netherlands). Each imaging study consisted of a low-dose CT scan (120 kV, 80mA)
followed by a dynamic 45-min list mode PET acquisition in a single bed position covering
the entire heart. 18FDG (155 ± 12MBq) and 68Ga-DOTA (142 ± 33MBq) were injected 1
and 6min after PET scan was started respectively. Both radiotracers were prepared in 6ml
and infused at a rate of 1.0ml/s through a peripheral ear vein, followed by a 6-ml saline
flush at the same rate. Arterial blood was withdrawn during the PET scan through a 1.6-
mm internal diameter peristaltic pump tubing (TYGON-XL6, Saint-Gobain, Courbevoie,
France) at 5ml/min for the first 7min and then at 2ml/min for the rest of the scan. Blood
collection from the coccygeal artery started immediately after the first radiotracer injection
and continued during the whole study. During the first 12min, blood was collected into
sample tubes according to the following scheme: 20 × 5 s, 8 × 10 s, 6 × 20 s, 24 × 5 s, 6 ×
10 s, 6 × 20 s, and 4 × 30 s. After that, 11 more samples were collected for 1min with 2-min
Fig. 4 a Calibration profiles obtained in the well counter for 300-μl pure 18F (red squares) and 68Ga (blue circles)
samples with different activity values using the full energy window (W200–2000). Each dataset was fitted to a straight
line with y-intercept forced to be 0 obtaining the calibration factors εF = 0.335 cps Bq−1 and εGa = 0.371 cps Bq−1 at
this volume. b Variation of calibration factors with the sample volume for 18F (εF) and 68Ga (εGa)
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gaps between consecutive samples. PET images were reconstructed with a voxel size of 4
mm × 4mm × 4mm using a 3D RAMLA reconstruction algorithm in 84 consecutive
frames (1 × 60 s, 25 × 5 s, 8 × 10 s, 4 × 20 s, 24 × 5 s, 3 × 10 s, 5 × 20 s, 5 × 60 s, 4 × 120 s, 4
× 180 s, and 1 × 300 s, total scan time 45min). Corrections for dead time, scatter, and ran-
dom coincidences were applied as implemented on the scanner. Decay and branching ratio
corrections were not applied as the amount of 68Ga and 18F on each voxel is unknown, and
their values differ (t1/2(
68Ga) = 67.77min and t1/2(
18F) = 109.77min, Br,Ga = 0.891 and Br,F =
0.967). Therefore, reconstructed images were expressed as β+decays·s−1 ml−1.
Separate AIF derivation from blood sample gamma spectroscopy
After each PET/CT examination, the vials containing the collected blood samples were
centrifuged briefly to provide a reproducible geometrical distribution of the blood be-
fore performing the measurements in the well counter. The volume for each blood
sample was determined as the weight difference between empty and filled vial and ap-
plying a blood density of 1.03 g/ml [15]. Then, the individual activity concentration of
18FDG and 68Ga-DOTA (AF and AGa) for each blood sample was calculated using (1–
3). Consequently, the AIFs obtained from blood samples for each tracer (AIFBS,F and
AIFBS,Ga) were derived as time series of these values.
Delay and dispersion corrections were applied to AIFBS,F and AIFBS,Ga using the image-
derived AIF (AIFID) as this one lacks delay and dispersion. AIFID was obtained from an 8-
mm diameter cylindrical volume of interest (VOI) drawn in the descending thoracic aorta
over five consecutive slices of the dynamic PET images. Spill-out from the AIF was cor-
rected normalizing to the activity measured inside a 10-mm-diameter spherical VOI
placed inside the left ventricle averaged over the latest frames. Delay was corrected by
maximizing the cross-correlation between AIFBS (sum of AIFBS,F and AIFBS,Ga) and
AIFID. In order to obtain dispersion-free AIFs, we assumed that at the moment of
the second tracer injection (at time t2), the blood concentration of the first tracer
was changing slowly and therefore did not suffer from dispersion. Thus, dispersion
before t2 is corrected by using the AIFID as there is only contribution from the
first tracer. After t2, we assume that AIFID,F and AIFBS,F are equal, and dispersion-
free AIF for the second tracer can be obtained by direct subtraction of AIFID and
AIFBS,F. Therefore, dispersion-free AIFF and AIFGa used for pharmacokinetic ana-
lysis can be derived as follows:
AI FGa ¼ f 0; j t < t2AI FID−AI FBS;F ; j t≥t2 ; AI F F ¼ f
AI FID; j t < t2
AI FBS;F ; j t≥ t2 ð4Þ
Kinetic modeling and image analysis
Parallel multi-tracer compartment modeling [3, 5, 16, 17] was applied to the recorded
PET data where each tracer’s kinetic behavior is introduced according to its pharmaco-
kinetic model and to its individual AIF. 68Ga-DOTA diffuses bidirectionally between
the intravascular and the interstitial space suggesting the use of a single-tissue compart-
ment model (1TCM) [10, 12] (see Fig. 5a). On the other hand, 18FDG is explained with
an irreversible two-tissue compartment kinetic model (2TCM) (Fig. 5b). Therefore, the
total tracer concentration measured in the tissue (Ctis) could be expressed as the sum
contribution from both tracers:
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Ctis tð Þ ¼
X
i¼Ga;F






  Cp;i tð Þ þ PVE tð Þ
ð5Þ
where IRFi({kj,i},t) is the impulse response function for tracer i, {kj,i} are the kinetic
parameters, Cp,i(t) is the activity concentration in plasma for tracer i, and PVE(t) de-
notes the spill-over of radioactivity coming from LV and RV into myocardium. These
IRFs can be described by the pharmacokinetic model that follows each tracer:
IRFGa K 1;Ga; k2;Ga; t
  ¼ K 1;Ga  e−k2;Gat ð6aÞ
IRFF K 1; F; k2; F; k3; F; t
  ¼ K 1;F k2;Fk2;F þ k3; F  e
− k2; Fþk3; Fð Þt þ k3;F
k2;F þ k3;F
 	 ð6bÞ
In order to obtain the free 68Ga-DOTA concentration in the plasma Cp,Ga(t),
hematocrit (H), and free metabolite fraction (b) must be used. These values have been
previously determined [14]. On the other hand, 18FDG concentration in the plasma for
myocardial tissue has already been described [18]. Therefore, the relation between
AIF(t) and Cp(t) for both tracers can be described as follows:
Cp;Ga tð Þ ¼ b1−H  AIFGa tð Þ ð7aÞ
Cp;F tð Þ ¼ 0:8þ 0:0012tð Þ  AIFF tð Þ ð7bÞ
PVE contribution was not split for each tracer as it can be considered a function of
the total blood activity concentration. It can be further decomposed in different com-
ponents as follows:
PVE tð Þ ¼ VAP  CAP tð Þ þ V LV  CLV tð Þ þ V RV  CRV tð Þ ð8Þ
where VLV, VRV, and VAP represent the spill-over fraction for the central LV, RV, and
apical LV respectively [19], and CLV, CRV, and CAP represent the corresponding time-
activity curves in those regions. The apical term was added to account for temporal
Fig. 5 Kinetic compartment models for 68Ga-DOTA (a) and 18FDG (b). The model for 68Ga-DOTA is a single-tissue
compartment model as the radiotracer diffuses bidirectionally between the intravascular space and extravascular
extracellular space (interstitial space). The model for 18FDG is an irreversible two-tissue compartment model as the
radiotracer diffuses bidirectionally between the intravascular and cellular space, and once it enters the myocyte, it
can phosphorylate to 18FDG-6-phosphate and remains trapped as it cannot be further metabolized
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differences observed between the central LV and the apical LV in swine hearts. The ob-
tained kinetic parameters were not affected by the fact that decay correction was not
applied to AIFs and Ctis functions as both are affected in the same way.
The model was applied on time-activity curves (TACs) obtained from PET images.
For that purpose, the myocardium was segmented using available software [20] follow-
ing the standard American Heart Association (AHA) 17-segment model [21], obtaining
one TAC (Ctis in (5)) per segment. CLV and CAP were obtained from spherical VOIs
drawn at the center (15 mm diameter) and apical (12 mm diameter) regions of the LV
respectively, while VOI for determination of CRV was manually drawn inside RV over
3–5 slices leaving a margin (> 5 mm) from the myocardium. The 5-parameter model
described on (5–8) was used to fit the data from each myocardial segment with a con-
strained Levenberg-Marquardt algorithm.
In vivo versus ex vivo myocardial tissue analysis
The concentration of both tracers at the end of the PET scan (Ctis,F(tend) and Ctis,Ga(-
tend)) was computed for each myocardial segment using (5). In addition, the corre-
sponding relative activities (RF,PET and RGa,PET) as well as standardized uptake values
(SUVF,PET and SUVGa,PET) were also derived in the same regions at the imaging end-
points, i.e., the values derived from the tracer distribution at the end of the PET scan.
In order to validate these results, analogous measurements were obtained from myocar-
dial tissue samples at the same regions of the same animals that had undergone the
PET examinations.
For that purpose, each animal was sacrificed at the end of the PET scans, and the
heart was excised and divided into 17 segments also following the AHA guidelines [21].
Each segment was further divided into 3 smaller portions to obtain triplicate measure-
ments. These 51 samples were weighted and measured in the well counter. In order to
increase the accuracy of myocardial samples analysis, the measurements in the well
counter were performed several times for each sample for 15 h using the full energy
window (W200–2000). Measurements were corrected for dead time and background. The
counts recorded as a function of time were fitted to a sum of two exponentials in order
to recover the contribution from each tracer as follows:
W 200−2000 tð Þ ¼ W F tð Þ þWGa tð Þ ¼ W F t0ð Þe−λ F t þWGa t0ð Þe−λGat ð9Þ
where λF and λGa are the radioactive decay constants for
18F and 68Ga respectively,
and WF and WGa are the counts measured in the well counter from each isotope.
WF(t0) and WGa(t0) were fitted using (9) and converted to activity using the corre-
sponding calibration factors (see Fig. 4). Activity values were decay corrected at sacri-
fice time (end of PET scan), and the ex vivo relative activities for 18FDG (RF,ex vivo) and
68Ga-DOTA (RGa,ex vivo) were obtained. The results obtained on each myocardial seg-
ment were averaged over triplicate samples. SUV values were also derived and extrapo-
lated to the imaging endpoints for each tracer (SUVF,exvivo and SUVGa,ex vivo).
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The 18FDG relative activities derived from tissue samples (RF,ex vivo) and from multi-
tracer PET imaging (RF,PET) were compared using Pearson’s correlation and the root
mean square error (RMSE), which is defined as follows:










vuut  100 ð10Þ
where s is the myocardial segment, and N is the number of myocardial segments ana-
lyzed (N = 17). In addition, SUV values derived from multi-tracer PET imaging were
compared with values obtained from excised myocardial segments. For any statistical
analysis, data are expressed as mean ± SD unless otherwise stated.
Results
Tracer separation by gamma spectroscopy
The results of the calibration procedure performed to separate the contribution of 18F-
and 68Ga-based tracers from blood samples containing a mixture of both tracers are
presented here. Figure 2 shows a linear behavior (r2 > 0.999) between the relative activ-
ity for 68Ga (RGa) of different
68Ga-18F mixture samples and the QS value measured in
the well counter. Figure 3 shows these QS values for pure
18F and 68Ga samples with
volumes ranging from 50 to 2000 μl. Of note, the well counter detection efficiency for
the high-energy gamma photon emitted by 68Ga is relatively higher at low sample vol-
umes probably due to geometric factors. When the sample volume is small, high energy
events represent about 4% of the total counts for 18F samples while it raises up to 10%
for 68Ga samples. QS(VS) profiles for
18F and 68Ga were fitted to a straight line and a
sum of two exponentials respectively in order to interpolate to any given sample vol-
ume. Figure 4a shows the calibrations performed to translate the measurements ob-
tained in the well counter using the full energy window to activity (data shown for 18F
and 68Ga). Data presented in Fig. 4a were obtained from 300-μl samples. However, the
calibration factors are also volume dependent. Therefore, the calibration was repeated
for different sample volumes to account for this effect (see Fig. 4b).
In vivo validation of multi-tracer PET against tissue analysis
Figure 6a shows an illustrative AIFBS,F and AIFBS,Ga obtained from collected blood sam-
ples that were analyzed using the gamma spectroscopy methodology previously de-
scribed. The corresponding AIFID is shown in Fig. 6b as well as the dispersion-free
AIFs for each tracer (AIFF and AIFGa) which were obtained using the methodology ex-
plained in its corresponding methods section.
Figure 7 illustrates myocardial tissue TACs (Ctis) obtained from dynamic PET data
for each of the animals included in this study. These TACs were fitted using the multi-
tracer compartment model shown in (5). The separate contribution obtained for 18FDG
and 68Ga-DOTA is presented in Fig. 7 along with the total tissue signal including the
spill-over.
Figure 8a shows the comparison of the relative activity for 18FDG obtained from
multi-tracer compartment modeling at imaging endpoints (RF,PET) and from excised
tissue (RF,ex vivo) for each animal and myocardial segment. An excellent correlation
was obtained (Pearson’s r = 0.95, p < 0.0001). Mean ± SD RF,PET (RF,ex vivo)
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obtained were 0.84 ± 0.03 (0.83 ± 0.02), 0.70 ± 0.03 (0.64 ± 0.02), and 0.91 ± 0.02
(0.91 ± 0.01) for animals 1, 2, and 3 respectively. These averaged results, as well as
RMSE and individualized SUVs for 18FDG and 68Ga-DOTA contributions, are pre-
sented in Table 1. SUV values obtained for 68Ga-DOTA were similar in all ani-
mals. SUVGa is low (~ 0.3) because this tracer reaches equilibrium between the
plasma and the interstitial space, and therefore, the tracer does not accumulate in
the tissue. On the other hand, low SUVF,PET were obtained for animals 1 (0.97)
and 2 (0.62) while higher values were obtained in the third animal (2.54). These
SUV values are highly correlated (Pearson’s r = 0.98, p < 0.0001) with those ob-
tained from excised tissue (SUVF,ex vivo and SUVGa,ex vivo). The lower RMSE value
calculated for the third animal is consistent with the higher SUVF obtained since
higher uptake leads to lower statistical noise in the pharmacokinetic analysis, as
well as in the measurements performed on excised tissue. In all cases, RMSE
values were below 7%.
Discussion and conclusions
In this study, we proposed a novel technique to perform multi-tracer PET imaging
using multi-tracer compartment modeling with explicit separation of individual AIF for
Fig. 6 a AIFBS,F (red) and AIFBS,Ga (blue) obtained from manual blood sampling during PET scan applying the
spectroscopic method. The black dashed line shows the sum of both tracers. b AIFID (black dashed line)
obtained from the dynamic PET images using an ROI drawn in the descending thoracic aorta and delay
corrected and dispersion-free contributions from 18FDG (red) and 68Ga-DOTA (blue) obtained as detailed in (4)
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each tracer. This technique relies on the use of two tracers with different isotopes with
at least one of them being a non-pure positron emitter. If the energy of the additional
gamma photons emitted by the non-pure positron emitter differs from the energy of
annihilation photons, a spectroscopic analysis of blood samples containing both tracers
can be performed in order to obtain the concentration of each individual tracer.
First, we developed a calibration procedure that allows the determination of indi-
vidual tracer concentration of samples containing an unknown mixture of the iso-
topes used in this study (18F and 68Ga). For that purpose, samples were analyzed
in a well counter recording event at two energy windows. The ratio between the
counts recorded in both energy windows was later employed to determine the
Fig. 7 Myocardial tissue TACs obtained from dynamic PET images for each animal included in this study
(black dashed lines). Data was fitted to the multi-tracer compartment model shown in (5) (purple line) and
separated into tissue TACs for 18FDG (red) and 68Ga-DOTA (blue)
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relative activity of each isotope. Corrections were made to account for different
sample volumes (see Fig. 3).
The proposed technique was implemented in vivo by performing cardiac PET/CT
studies on three healthy pigs, which were injected with 18FDG and 68Ga-DOTA during
the same acquisition and validated against their analogous ex vivo measurements. A
45-min dynamic PET scan was performed on each animal, and blood samples were col-
lected during the entire acquisition and further analyzed with the well counter to deter-
mine the AIF for each tracer. A multi-tracer compartment model was later applied to
recover the individual tissue TAC for each tracer on individual myocardial segments
(see Fig. 7). Imaging endpoint concentrations were validated against both 18FDG and
68Ga-DOTA concentration measured with the well counter on excised myocardial tis-
sue. Results show that the proposed multi-tracer PET imaging technique offers very
similar results to those obtained as a reference from ex vivo analysis (see Fig. 8), with
RMSE below 7% in all cases. Moreover, SUV for 68Ga-DOTA and 18FDG was obtained
showing normal 68Ga-DOTA uptake for healthy pigs [12] and variable 18FDG uptake as
expected, since no prior glucose load was used [22]. An overestimation of SUVex vivo
values compared with SUVPET values can be observed, which might be explained by
partial volume effect in PET data.
The proposed technique allows performing PET scans with two tracers during the
same acquisition obtaining separate information from each tracer. This new method al-
lows explicit measurement of separate AIF for each tracer while other existing methods
rely on AIFs based on representative patients [23] or using extrapolation techniques
Fig. 8 Linear correlation between relative activities for 18FDG (a) and between SUVs for both 18FDG and 68Ga-
DOTA (b) obtained from multi-tracer compartment modeling at imaging endpoints (RF,PET, SUVPET) and from
excised tissue (RF,ex vivo, SUVex vivo). Each dot represents one of the 17 myocardial segments for each animal. The
results are highly correlated (Pearson’s r = 0.95, p < 0.0001 for relative activities and r = 0.98, p < 0.0001 for SUVs)
Table 1 RF,PET and RF,ex vivo values are represented as the mean ± SD of all the myocardial
segments analyzed for each animal along with their comparison obtained using the RMSE value.
Mean ± SD SUV for each tracer obtained from multi-tracer PET analysis and excised tissue are also
shown
Animal RF,PET RF,ex vivo RMSE (%) SUVGa,PET SUVGa,ex vivo SUVF,PET SUVF,ex vivo
1 0.84 ± 0.03 0.83 ± 0.02 3.6 0.30 ± 0.07 0.51 ± 0.09 0.96 ± 0.15 1.56 ± 0.14
2 0.70 ± 0.03 0.64 ± 0.02 6.8 0.27 ± 0.08 0.39 ± 0.03 0.60 ± 0.16 0.65 ± 0.03
3 0.91 ± 0.02 0.91 ± 0.01 1.7 0.28 ± 0.05 0.54 ± 0.06 2.55 ± 0.26 4.65 ± 0.36
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[24]. However, our technique requires using at least one tracer based on a non-pure
positron emitter, preventing the combination of tracers based on the same isotope. On
the other hand, 68Ga is a suitable isotope for this technique. 68Ga has emerged as a very
promising isotope for PET imaging with many relevant applications in clinical diagnosis
[8]. Therefore, further combinations of tracers based on 18F and 68Ga, different from
that shown in this study, might benefit from this work. Another limitation of our
method is that it is invasive as it requires the collection of blood samples while other
methods are non-invasive. Separation of AIFs could be generally applied using chroma-
tographic techniques [25] although this is a very time-consuming process, and only a
few blood samples could be analyzed.
Other techniques for multi-tracer PET imaging which use non-pure positron emitters
with prompt gamma emissions record coincidence events with the PET scanner contain-
ing annihilation and prompt gamma photons, which are later used in the reconstruction
process to separate the contribution from each tracer [6]. However, a higher branching ra-
tio of the prompt gamma photons is required to obtain enough sensitivity of this type of
events, and therefore, those techniques are limited to less common isotopes like 124I. It
should be noted that in the proposed method, the additional gamma photons emitted by
the non-pure positron emitter can be delayed with respect to the positron decay as they
do not have to be detected in coincidence for the spectroscopic analysis.
In this study, the spectroscopic analysis of the blood samples was performed using a
well counter. However, an online blood sampling detector [26, 27] could be also used,
which would further simplify the implementation of this technique. We recently devel-
oped a novel blood sampling detector and successfully tested it in vitro for multi-tracer
measurements based on the spectroscopic analysis [28]. In that case, the blood would
be extracted from the patient through a catheter that would pass through a gamma
photon detector, and a similar methodology to the one applied with the gamma coun-
ter would be used. In that way, AIF separation could be obtained immediately while
minimizing the radiation exposure of the personnel and avoiding technical issues such
as volume dependence of blood samples.
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